Abstract
From the first initiatives in preimplantation genetic diagnosis (PGD) and gene therapy through the advent of stem cell research to the development of mammalian cloning, the past two decades have witnessed remarkable advances in “reprogenetic” medicine: the union of assisted reproductive technologies (ARTs) with genetic control. This period has also been marked by intense debates within the bioethical literature and in national policy forums about the appropriate uses of these emerging human capabilities. We can now, in a limited way, select for genetic traits, and the power to modify the genome or introduce new gene sequences is not far off. How should these new powers be used?
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,Issues, ethics and legal aspects,Health(social science)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protecting Humanity;Cambridge Quarterly of Healthcare Ethics;2012-02-29
2. Rationality and the Genetic Challenge Revisited;Cambridge Quarterly of Healthcare Ethics;2011-05-20